Raloxifene for prevention of osteoporotic fractures.
Diehr
Sabina
S
Medical College of Wisconsin, Milwaukee 53226, USA.
Mijal
Sara
S
Nashelsky
Joan
J
D019317:Evidence-Based Medicine; D005260:Female; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000150:complications*; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D020849:Raloxifene Hydrochloride / Q000494:pharmacology / Q000627:therapeutic use*; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride